Detalhe da pesquisa
1.
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Mol Cell Proteomics
; 18(6): 1255-1268, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154438
2.
ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide.
Pharmacogenomics J
; 20(2): 213-219, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624332
3.
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Mol Cell Proteomics
; 17(11): 2132-2145, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30072578
4.
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors.
Cancer Invest
; 36(9-10): 512-519, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30727779
5.
Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan.
Cancer Invest
; 36(2): 165-174, 2018 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29393706
6.
Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
J Neurooncol
; 137(3): 533-542, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305787
7.
DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas.
Int J Mol Sci
; 19(3)2018 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29495584
8.
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
Eur J Nucl Med Mol Imaging
; 44(3): 373-381, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27554774
9.
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients.
BMC Cancer
; 17(1): 278, 2017 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420326
10.
Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Acta Oncol
; 56(12): 1776-1785, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675067
11.
Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.
Cancer Cell Int
; 16: 34, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118928
12.
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.
Acta Oncol
; 55(4): 418-22, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26828563
13.
Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma.
Mol Cell Proteomics
; 18(6): 1270, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154440
14.
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.
Acta Oncol
; 53(7): 939-44, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24456504
15.
Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy.
Sci Rep
; 14(1): 10985, 2024 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744979
16.
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.
BMC Cancer
; 13: 402, 2013 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24004722
17.
Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme.
J Neurooncol
; 111(2): 205-12, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23184145
18.
A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis.
Neurooncol Adv
; 5(1): vdad099, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706198
19.
Evaluation of the HD-GLIO Deep Learning Algorithm for Brain Tumour Segmentation on Postoperative MRI.
Diagnostics (Basel)
; 13(3)2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36766468
20.
Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.
Exp Cell Res
; 317(11): 1513-26, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21514294